Green tea polyphenols alter lipid metabolism in the livers of broiler chickens through increased phosphorylation of AMP-activated protein kinase

Jinbao Huang; Yibin Zhou; Bei Wan; Qiushi Wang; Xiaochun Wan

doi:10.1371/journal.pone.0187061

Abstract

Our previous results showed that green tea polyphenols (GTPs) significantly altered the expression of lipid-metabolizing genes in the liver of chickens. However, the underlying mechanism was not elucidated. In this study, we further characterized how GTPs influence AMP-activated protein kinase (AMPK) in the regulation of hepatic fat metabolism. Thirty-six male chickens were fed GTPs at a daily dose of 0, 80 or 160 mg/kg of body weight for 4 weeks. The results demonstrated that oral administration of GTPs significantly reduced hepatic lipid content and abdominal fat mass, enhanced the phosphorylation levels of AMPKα and ACACA, and altered the mRNA levels and enzymatic activities of lipid-metabolizing enzymes in the liver. These results suggested that the activation of AMPK is a potential mechanism by which GTPs regulate hepatic lipid metabolism in such a way that lipid synthesis is reduced and fat oxidation is stimulated.

Citation: Huang J, Zhou Y, Wan B, Wang Q, Wan X (2017) Green tea polyphenols alter lipid metabolism in the livers of broiler chickens through increased phosphorylation of AMP-activated protein kinase. PLoS ONE 12(10): e0187061. https://doi.org/10.1371/journal.pone.0187061

Editor: Hong Wang, Rutgers, the State Univesity of New Jersey, UNITED STATES

Received: July 18, 2017; Accepted: October 12, 2017; Published: October 26, 2017

Copyright: © 2017 Huang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting Information files.

Funding: This work was supported, in whole or in part, by Anhui Major Demonstration Project for Leading Talent Team on Tea Chemistry and Health (www.ahedu.gov.cn); the Natural Science Foundation of Anhui province, China (Grant No. 1608085MC54, www.ahkjt.gov.cn); the Natural Science Foundation of the Anhui Higher Education Institutions of China (Key project, Grant No. KJ2015A060, www.ahedu.gov.cn), Youth Science Foundation of Anhui Agricultural University (Grant No. 2014zr009, www.ahau.edu.cn), Talent Foundation of Anhui Agricultural University (Grant No. yj2015-19, www.ahau.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

Introduction

Lipid metabolism in the liver is vitally important for energy homeostasis. Regulation of the expression of genes encoding lipid metabolic enzymes plays a central role in the responses to changes in dietary, nutritional and physiological states. In the treatment of diabetes and obesity with pharmacological agents, the liver is often the target organ[1–3]. Some of these interventional agents, such as metformin, have been shown to increase catabolism in the liver, which yields beneficial effects in diabetic patients.

Some natural products, such as green tea, have also been shown to reduce body weight gain and alter the regulation of glycolipid metabolism of animals in vivo [4]. Green tea is one of the most popular beverages in the world. Studies have illustrated that green tea alters fat metabolism [5], likely through the activities of tea polyphenols, among which the catechin (-)-epigallocatechin-3-gallate (EGCG) is the most abundant compound [4]. After the ingestion of tea, EGCG can be detected in the liver[6], indicating that the liver is susceptible to the intervention of dietary catechins. However, the relative importance of this active ingredient under different experimental conditions remains unclear.

Our previous data demonstrated that green tea polyphenols (GTPs) decreased the mRNA level of some lipogenic genes and elevated the expression of several key genes in the fatty acid oxidation pathway in the liver of broiler chickens [7]. However, both the GTP target and the cellular activities GTP influences remained unknown.

A possible target is the AMP-activated protein kinase (AMPK), a vital sensor of energy metabolism at the cellular and whole-organ levels [8]. Activated AMPK can phosphorylate and inhibit acetyl-CoA carboxylase (ACACA), which results in lower malonyl-CoA levels and removal of the inhibition of carnitine palmitoyl transferase 1 (CPT1A) [8]. It has been reported that green tea extract, tea polyphenols, and EGCG could activate hepatic AMPK in rodents and/or cell lines[9–11]. We hypothesized that GTPs would target AMPK in chickens.

To elucidate whether green tea influences the activity or phosphorylation state of AMPK, we examined how GTP treatment of broiler chickens affected AMPK phosphorylation and gene expression of known downstream genes in the liver. Unlike in mammals, the liver of avian species accounts for 95% of de novo fatty acid synthesis, making it the most important organ for lipogenesis in the body. Because of this difference in lipid metabolism between birds and mammals, our study provides a unique perspective on the lipid-lowering efficacy of green tea. This data can be further used to develop feed that could result in healthier chickens for human consumption.

Materials and methods

Reagents

Green tea polyphenols (GTPs) were purchased from Wuhu Tianyuan Science and Technology Development Co., Ltd. (Anhui, China). The catechin composition (the most important bioactive constituents of green tea) of the GTPs used in this study was assayed by HPLC and found to contain gallic acid (GA, 0.7%), catechin (C, 1.09%), epicatechin (EC, 4.69%), gallocatechin gallate (GCG, 6.23%), epigallocatechin (EGC, 7.63%), epicatechin gallate (ECG, 11.46%), and EGCG (53.1%). The remaining ingredients of the GTP extract (approximately 15%) were anthocyanins, leucoanthocyanins and phenolic acids. Other reagents were either analytical or molecular grade.

Animal feeding and sampling

Male broiler chicks (Ross 308, Gallus gallus domesticus) were obtained from a local hatchery and subsequently raised in a standard chicken facility. The breeding room temperature was maintained at 21°C [45% relative humidity (RH)]. All chickens were provided a grower diet with 19% crude protein and 12.98 MJ/kg metabolizable energy. All birds were given ad libitum access to food and water during the entire rearing period.

Animal handling procedures were similar to our previous experiment[7]. All animal experiments were performed in accordance with the ‘‘Guidelines for Experimental Animals” (GB14925-2010, the General Administration of Quality Supervision, Inspection and Quarantine and the Standardization Administration of the People's Republic of China). All animal protocols were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Anhui Agricultural University.

In brief, thirty-six 28-day-old male broilers with comparable body weight were randomly divided into 3 groups (2 chickens per cage; 6 cages per group). After acclimation for 3 days, all animals in each group started to receive one of the following daily oral treatments at 9:00 A.M. for 4 weeks: Control treatment (deionized water); GTP treatment at 80 mg/kg body weight; or GTP at 160 mg/kg body weight. The GTP solutions were freshly prepared in deionized water one hour before oral administration. GTP doses chosen in this research were based on our former results, which is comparable to 0.15% ~ 0.30% dietary GTPs, similar to doses used in rodent studies[12].

On the mornings of days 14 and 28, 6 chickens, one from each cage, were randomly selected from each treatment group. The birds were anesthetized with pentobarbital sodium by intraperitoneal injection. After confirming the effectiveness of the anesthesia by a lack of responsiveness to toe pinching, the chickens were humanely sacrificed by exsanguination. After that, the intraperitoneal cavities were opened and the liver and abdominal fat were harvested, weighed, and washed with ice-cold saline. Liver samples (approximately 100 mg) were placed into 1.5 ml-tubes containing RNAstore reagent (Tiangen, Beijing, China) and stored at -80°C until further analysis of gene expression. The remaining liver samples were immediately frozen in liquid nitrogen and then stored at -80°C.

Evaluation of hepatic lipid content and fatty acid profile

One gram of liver tissue sample was placed in a 50-ml conical tube, mixed with a chloroform:methanol mixture (2:1, v/v) to a final volume of 20 ml, and homogenized by an IKA T-25 homogenizer in an ice bath for 1 min. The tube was then placed in a shaker at room temperature for 1 h before the protein and connective tissues were removed by vacuum filtration on a Buchner funnel with fat-free filter paper. A solution of physiological saline (20% of the volume of the filtrate) was added and vortexed for several seconds. The tube was centrifuged at 3000 rpm for 15 min. The supernatant was discarded, and the chloroform phase was collected. When needed, the interface of the two phases was washed with a 1:1 water:methanol mixture once or twice. Finally, the chloroform fraction containing the lipid was concentrated by rotary evaporation or by blowing with a stream of nitrogen and precisely weighed to calculate the percent of lipid in the sample (fresh weight). Fatty acid composition was analyzed according to the method of Kandhro et al. [13]. Briefly, the fatty acids were analyzed on an Agilent 6890A gas chromatography instrument (Agilent Technologies, NY). A DB-23 capillary column that was 60 m × 0.25 mm i.d with a 0.25 μm film (Agilent Technologies, Palo Alto, CA) was used for the separation of fatty acid methyl esters. Peak identification was carried out by comparison with the retention times and mass spectra of the known standards. Standard methyl esters of palmitic (76119), stearic (85679), oleic (75090) and linoleic (62230) acids (Sigma-aldrich, CA) were used for confirmation of the mass spectral library (NIST11) identifications.

Real-time PCR analysis

The expression levels of key genes in the lipid metabolizing pathway were measured using real-time quantitative PCR (RT-qPCR). RNA extraction, reverse transcription and RT-qPCR were the same as our previous study [7]. In brief, total RNA from the liver sample was isolated using a commercial kit (Tiangen, DP431, Beijing, China). Reverse transcription was performed immediately following the total RNA isolation using a first strand cDNA synthesis kit (Takara, 6110A Dalian, China). RT-qPCR was performed using the CFX96^TM Real-Time System (Bio-Rad, CA). The expression level of target mRNA was normalized to the mRNA level of beta-actin. The linear amount of the target gene expression to the internal standard was calculated by 2^-△△CT. The gene sequences involved in the present study were obtained from GenBank (www.ncbi.nlm.nih.gov/Genbank), and the accession numbers and sequences of the primers used are listed in Table 1.

Download:

Table 1. Gene-specific primers for mRNA amplification of key lipid metabolism genes.

https://doi.org/10.1371/journal.pone.0187061.t001

SDS-PAGE and Western blotting

The liver samples were homogenized in lysis buffer (containing proteinase and phosphatase inhibitors) using a motor-driven pestle in a 1.5-ml conical tube. After being stored on ice for 30 min, the homogenates were centrifuged at 4°C at 12,000 x g for 45 min. The supernatants were harvested, and the protein concentrations were measured. Western blotting followed the procedure of Murase et al. [11]. The bands of the target protein were obtained using a chemiluminescence reagent (Thermo Scientific, MA) and a ChemiDoc XRS imaging system (Bio-Rad, CA).

Primary antibodies for ACACA (Thermo, PA5-17564), phospho-acetyl-CoA carboxylase (Ser79) (Cell Signaling Technologies, #03661, MA), phospho-AMPKα (Thr172) (Millipore, #07–626, MA), and GAPDH (Santa cruz, sc-20357, TX) were used in this experiment. These antibodies were all validated for use with chicken samples according to the instructions of the companies.

Activity of lipid metabolic enzymes

The activities of hepatic AMPK (GMS50140.2.3), ACACA (GMS50510.2), FASN (GMS50509.2) and CPT1A (GMS50118.2.2) were determined using analytical kits (Genmed Scientifics, MA).

The activity of AMPK was measured by the phosphorylation of a synthetic `SAMS' peptide in a pyruvate kinase—lactate dehydrogenase reaction system. The transformation of reduced nicotinamide adenine dinucleotide (NADH) to nicotinamide adenine dinucleotide (NAD) was measured to determine the amount of ADP produced by the phosphorylation reaction. The pyruvate kinase—lactate dehydrogenase reaction determines the content of ADP. The analysis of ACACA activity was also based on the amount of ADP generated from the ACACA-catalyzed reaction. The CPT1A activity was assayed spectrophotometrically in supernatants of homogenized liver tissues by following the release of CoA-SH from palmitoyl-CoA using the general thiol reagent DTNB (5,5-dithiobis-(2-nitrobenzoic acid)) in Tris-HCl–DTNB buffer (116 mM Tris, 2.5 mM EDTA, 2 mM DTNB, 0.2% Triton X-100, pH 8.0). The activity of FASN was analyzed by the amount of nicotinamide adenine dinucleotide phosphate (NADP⁺) generated from the FASN catalysis reaction using acetyl CoA, malonyl CoA and reduced nicotinamide adenine dinucleotide phosphate (NADPH) as substrates.

Measurement of the concentration of hepatic malonyl-CoA

The concentration of hepatic malonyl-CoA was measured by an ELISA kit (Shanghai Jianglai Biological Technology Co., Ltd, JL21634, Shanghai, China) according to supplier instructions.

Statistical analysis

Experimental data were analyzed by the IBM SPSS Statistics 22.0 software (IBM, Armonk, New York, USA). One-way ANOVA and Tukey multiple-range analysis methods were employed to assess the significance of GTP treatments.

Results

GTP supplementation on the liver-to-body ratio and abdominal fat mass

During the experimental period, the feed intake and body weight were monitored. Our data indicated that 2 and 4 weeks of GTP treatment did not affect the feed consumption or body weight gain in the experimental birds (Table 2). After 2 weeks of supplementation with GTPs, the liver/body weight ratio and the abdominal fat mass of chickens showed no significant differences among the three groups (Table 2). However, after 4 weeks, the abdominal fat mass of birds fed 80 and 160 mg/kg GTP significantly decreased by 31.82% (p < 0.01) and 34.29% (p < 0.01), respectively (Table 2). Additionally, the 160 mg/kg GTP group showed a significantly reduced liver/body weight ratio after 4 weeks of treatment (Table 2).

Download:

Table 2. Effects of green tea polyphenols on feed intake, body weight, liver-to-body weight ratio, and abdominal fat mass in broiler chickens.

https://doi.org/10.1371/journal.pone.0187061.t002

GTP supplementation on the hepatic lipid content and oleic acid proportion

After 2 weeks of treatment with GTPs, no significant differences in liver fat content were observed among the different groups. However, after 4 weeks of treatment, the animals fed GTP showed significantly reduced hepatic lipid levels. The animals supplemented 80 mg/kg and 160 mg/kg GTPs had 7.46% and 8.0%, respectively, lower hepatic fat levels (Table 3). It is worth noting that the changes in liver fat composition appeared to start earlier. After 2 weeks, the ratios of oleic acid to total fatty acids were significantly decreased in broilers fed 80 and 160 mg/kg GTPs (by 24.5% and by 38.5%, respectively; Table 3). A similar reduction in hepatic oleic acid was also observed after 4 weeks of GTP treatment.

Download:

Table 3. Effects of green tea polyphenols on the fat profile and malonyl-CoA content in the liver of broilers.

https://doi.org/10.1371/journal.pone.0187061.t003

GTPs altered the expression of lipid-metabolizing genes in the liver

To elucidate how GTPs modulate lipid metabolism, the gene expression of some key enzymes and factors in the fat metabolizing pathway were determined using RT-qPCR. After 2 weeks of supplementation with 160 mg/kg of GTPs, the expression levels of hepatic FASN and ACACA were significantly decreased, by 61.2% and 33.7%, respectively (Fig 1A and 1B). The mRNA levels of these two lipid synthesis genes were not significantly altered in chickens fed 80 mg/kg GTPs. After 4 weeks of treatment, the expression levels of FASN and ACACA in the livers of broilers fed 80 mg/kg GTPs were reduced by 28.4% and 14.6%, respectively, and in the livers of broilers fed 160 mg/kg by 74.8% and 48.1%, respectively (Fig 1A and 1B). The expression of the desaturase SCD1 was sharply decreased by both doses of GTPs after treatment for 2 or 4 weeks (Fig 1C). The hepatic mRNA levels of SCD1 were significantly lowered after 2 weeks by 68.7% or 92.3%, respectively, with the treatment of 80 or 160 mg/kg of GTPs, and after 4 weeks by 78.4% and 94.1%, respectively, by the low and high doses of GTPs.

Download:

Fig 1. Effects of GTPs on the mRNA expression levels of representative fatty acid synthesis genes in the liver.

Broilers were treated with vehicle (distilled water), 80 mg/kg GTPs, or 160 mg/kg GTPs for 2 or 4 weeks: A, fatty acid synthase (FASN); B, acetyl-CoA carboxylase (ACACA); C, stearoyl-coenzyme A desaturase 1 (SCD1); D, Sterol regulatory element-binding protein-1c (SREBP-1c). Values are represented as the means ± SEM (n = 6). Statistical significance was determined by ANOVA with Duncan's multiple-range test, with levels of significance at *p < 0.05, **p < 0.01, and ***p < 0.001 compared with the control.

https://doi.org/10.1371/journal.pone.0187061.g001

Treatment with GTPs also strongly repressed hepatic gene expression of a lipid metabolism-related transcription factor. The gene expression of SREBP-1c in the livers of chickens supplemented 160 mg/kg GTP was reduced by 33.1% or 39.2% after 2 or 4 weeks, respectively (Fig 1D).

On the other hand, GTP treatment significantly increased the mRNA expression levels of beta-oxidation genes in the liver (Fig 2). After 2 weeks, the expression level of hepatic CPT1A was significantly enhanced, by 79.3% and 87.4% in the animals from the 80 and 160 mg/kg GTP-treatment groups, respectively (Fig 2A). The gene expression levels of acyl-CoA oxidase 1 (ACOX1) during this period was also significantly increased, by 151.2% and 116.3% in the 80 mg/kg and 160 mg/kg GTP-treatment groups, respectively (Fig 2B).

Download:

Fig 2. Effects of GTPs on mRNA expression levels of representative lipolysis genes in the liver.

Broilers were treated with vehicle (distilled water), 80 mg/kg GTPs, or 160 mg/kg GTPs for 2 or 4 weeks: A, carnitine palmitoyl transferase I (CPT1A); B, acyl-CoA oxidase 1 (ACOX); and C, peroxisome proliferator-activated receptor-alpha (PPARα). Values are represented as the means ± SEM (n = 6). Any statistical significance was determined by ANOVA with Duncan’s multiple-range test, with levels of significance at ** p < 0.01 and *** p < 0.001 compared with the control.

https://doi.org/10.1371/journal.pone.0187061.g002

Similarly, after 4 weeks, a 2.60- and 1.33-fold up-regulation in CPT1A and ACOX1 gene expression, respectively, was observed after treatment with 160 mg/kg GTPs; however, no significant changes were found with the 80 mg/kg GTP treatment at this longer time point. Additionally, the mRNA level of the transcription factor PPARα was significantly enhanced in the liver following 4 weeks of supplementation with 80 mg/kg and 160 mg/kg GTPs (Fig 2C).

GTPs alter the activity of lipid metabolic enzymes in the liver

To further verify the effects of GTPs on fat metabolism in the liver, the activities of some fat metabolizing enzymes were examined. Our data showed that the activities of hepatic ACACA and FASN were significantly decreased, by 16.8% and 47.8%, respectively, after treatment with 160 mg/kg GTPs for 2 weeks (Fig 3A and 3B). After treatment for 4 weeks, the FASN activities were significantly suppressed by 32.1% and 44.7%, in the livers of chickens fed 80 and 160 mg/kg GTPs, respectively. After 2 weeks, the enzymatic activity of CPT1A was significantly increased, by 59.4% and 134.2% in chickens supplemented 80 and 160 mg/kg of GTPs, respectively (Fig 3C). After 4 weeks of treatment, the increase in CPT1A activity was not significant. Also after 2 weeks, the activity of hepatic AMPK was significantly increased, by 78.3% and 93.7% in chickens fed 80 and 160 mg/kg GTPs, respectively (Fig 3D). After 4 weeks, however, no significant difference was observed in the hepatic AMPK activities among the three treatment groups.

Download:

Fig 3. Effects of GTPs on lipid-related enzyme activities in the liver.

Broilers were treated with vehicle (distilled water), 80 mg/kg GTPs, or 160 mg/kg GTPs for 2 or 4 weeks: A, fatty acid synthase (FASN); B, acetyl-CoA carboxylase (ACACA); C, carnitine palmitoyl transferase I (CPT1A); and D, AMP-activated protein kinase (AMPK). Values are represented as the means ± SEM (n = 6). Statistical significance was determined by ANOVA with Duncan's multiple-range test, with * p < 0.05, ** p < 0.01, and *** p < 0.001 representing significant differences compared with control.

https://doi.org/10.1371/journal.pone.0187061.g003

GTPs influence on malonyl-CoA concentration in the liver

To further study the regulatory effects of GTPs on hepatic fatty acid metabolism, we examined the malonyl-CoA content in the liver (Table 3). After 2 weeks of treatment with 160 mg/kg GTPs, the malonyl-CoA content in the liver was significantly reduced, by 29.3%. After 4 weeks of treatment with 80 or 160 mg/kg GTPs, the hepatic malonyl-CoA content was significantly reduced, by 33.8% or 39.5%, respectively.

GTPs affect the phosphorylation levels of hepatic AMPK and ACACA

To determine if AMPK plays a role in the GTP regulation of lipid-metabolizing genes in the liver, the levels of phosphorylated AMPKα and ACACA in the liver were examined. After 2 weeks of treatment with 80 or 160 mg/kg GTPs, the phospho-AMPKα level was significantly increased, by 63.6% or 101.3%, respectively (Fig 4). However, this effect on phospho-AMPKα was not observed after 4 weeks of treatment (Fig 4). After two or four weeks, the mRNA levels of hepatic AMPKα1 and AMPKα2 were not altered in both GTP treatments (S1 Fig). As a phosphorylation target of AMPK, the level of phospho-ACACA was similarly altered by GTP treatment. A significantly elevated level of phospho-ACACA was observed after 2 weeks of treatment, but not after 4 weeks of treatment (Fig 4).

Download:

Fig 4. Phosphorylation of hepatic AMPKα and ACACA in broilers treated with green tea polyphenols.

Broilers were treated with vehicle (distilled water), 80 mg/kg GTPs, or 160 mg/kg GTPs for 2 or 4 weeks. Western blots were probed with antibodies targeting phosphorylated version of ACACA, acetyl-CoA carboxylase and AMPK, AMP-activated protein kinase or unphosphorylated version of ACACA and GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Values are represented as the means ± SEM (n = 6); statistical significance was determined by ANOVA with Duncan's multiple-range test, with *p < 0.05 and **p < 0.01 compared with control.

https://doi.org/10.1371/journal.pone.0187061.g004

Discussion

In animals, lipid synthesis occurs at two major sites: the liver and in adipose tissue. The relative contribution of these sites to lipogenesis varies among species. Differences in the site of fatty acid synthesis and the pattern of lipid trafficking influence not only the overall lipid metabolism in the animal but also the roles of regulatory hormones and transcription factors [14]. For example, hepatic and adipose tissues equally contribute to lipid synthesis in rodents, while in avian species lipogenesis occurs principally in the liver[15]. In this study, we used broiler chickens as a model to investigate metabolic effects of GTPs on lipid synthesis to generate data comparable to that on rodents, in which the benefits of green tea polyphenols on lipid metabolism have been studied extensively.

In this study, GTP supplementation significantly decreased abdominal fat mass and hepatic lipid content in broiler chickens. GTP treatment also altered the mRNA levels of lipid-metabolizing genes in the liver. It is worth mentioning that significant changes in hepatic lipid content were only observed after 4 weeks of treatment. However, most molecular changes in the liver of GTP-treated birds could be detected after 2 weeks, indicating that the expression levels of functional genes were affected before body fat changes were observed. Our data showed that gene expression and enzyme activities of the de novo lipid synthesis proteins (FASN and ACACA) in the liver were both suppressed by oral administration of GTPs after 2 and 4 weeks. SCD1 is a key enzyme in monounsaturated fatty acids (Δ⁹) synthesis, which play vital roles in the synthesis of cholesterol esters and triglycerides [16]. In our study, 2 and 4 weeks of treatment with GTPs, especially the higher dose, decreased the gene expression of hepatic SCD1, which was accompanied by a decrease in the ratio of hepatic oleic acid to total lipid content. Our data demonstrated that oral administration of GTPs suppressed fat synthesis in the liver and, considering the role of monounsaturated fatty acids (Δ⁹) in the synthesis of triglycerides and low-density lipoprotein cholesterol, could decrease the lipid content in the extrahepatic tissues of birds.

SREBP-1c is expressed abundantly in the livers of animals and acts as a transcription factor activating lipid synthesis genes such as ACACA, FASN and SCD-1 by binding their promoter regions [17–19]. The reduction of SREBP-1c gene expression in the liver of chickens fed GTP administration is consistent with the decreased hepatic expression of FASN, ACACA and SCD1. In the livers of fructose-fed mice with non-alcoholic fatty acid liver disease, SREBP-1c and its target genes (FASN, ACACA and SCD1) were highly expressed through activation of endoplasmic reticulum (ER) stress in these animals, which subsequently increased lipid synthesis and accumulation in the liver[20]. Recently, it was also suggested that expression of SREBP-1c could be significantly inhibited by leptin[21–23].

In this study, GTP treatment also enhanced the mRNA levels and enzyme activities of lipid-catabolizing genes in the livers. PPARα is a nuclear receptor that is often highly expressed in tissues with a high rate of fatty acid beta-oxidation, such as brown adipose tissue, liver, heart, and muscle, in both avian and mammalian species [24–26]. Its high expression in the liver could enhance the mRNA levels of hepatic CPT1A and ACOX1 [27–29]. These reports are consistent with our results showing that 2 weeks of GTP treatment increased expression of PPARα and the fatty acid beta-oxidation rate-limiting enzymes CPT1A and ACOX1, as well as the increased enzymatic activity of CPT1A.

The present results showing that GTPs suppress the gene expression and enzyme activities of lipid anabolism enzymes and increase the mRNA levels and enzyme activities of lipid catabolism enzymes are consistent with the results from studies with green tea extracts or polyphenols observed in obese mouse and rat models[30–33]. To further characterize the GTP-responsive pathway regulating hepatic lipid metabolism, changes in AMPK were investigated. AMPK is a cellular energy sensor that can switch cellular metabolism from anabolic to catabolic mode[34]. Our data demonstrated that the content of phospho-AMPKα was significantly enhanced in the liver of GTP-treated chickens. Due to the lack of suitable antibodies for AMPKα in chicken, we did not measure the total protein content of AMPKα. However, the data showed that GTP supplementation increased both the activity of hepatic AMPK and the ratio of phosphorylated ACACA and decreased the ACACA activity and the malonyl-CoA level in the liver, suggesting that activating hepatic AMPK is a potential mechanism by which GTPs regulate lipid metabolism in broiler chickens.

In recent years, the effects of tea polyphenols on the AMPK-dependent pathway have been studied using rodents and/or cell lines. For example, green tea extracts (i.g., 50 and 100 mg/kg) in mice have been shown to increase the hepatic phosphorylation of AMPK, as well as its upstream kinase, LKB1, at 3 and 6 h after dosing[9]. The lipid-lowering effect of green tea in high fructose-fed rats was associated with increased AMPK phosphorylation[10]. Orally administered EGCG in mice stimulated energy expenditure, which was also associated with increased phosphorylation of AMPK [11]. AMPK is a short-term sensor of energy metabolism, and an increase in its phosphorylation state can be observed a few hours after administration of green tea polyphenols. In our study, GTP treatment enhanced AMPK phosphorylation at 2 weeks. However, no significant effect of GTPs treatment on phospho-AMPK was observed at 4 weeks. This may be related to an adaptive metabolic response in the liver of birds or an enhanced elimination of catechins during prolonged experimental times. In rats treated with 0.6% GTPs in drinking water, Kim et al. showed that plasma concentrations of catechins reached peak values on day 14 and then slowly decreased to day 1 values on day 28 [35]. Since AMPK is a short-term sensor of energy, the lack of longer-term effects on phosphorylated AMPK may be caused by the decreased level of plasma GTPs in birds. These possibilities remain to be investigated.

Concluding remarks

Our data demonstrated that the oral administration of green tea polyphenols (GTPs) significantly decreased lipid content, enhanced the levels of phosphorylated AMPKα and ACACA, and altered the mRNA levels and enzymatic activities of lipid-metabolizing enzymes in the livers of broiler chickens. We propose that the activation of AMPK is a potential mechanism through which GTPs alter metabolism, which consequently reduces lipid synthesis and stimulates fat oxidation in the liver.

Supporting information

S1 Fig. Effects of GTPs on mRNA levels of AMPK genes in the liver.

Broilers were treated with vehicle (distilled water), 80 mg/kg GTPs, or 160 mg/kg GTPs for 2 or 4 weeks.

https://doi.org/10.1371/journal.pone.0187061.s001

(TIF)

S1 Table. Raw data for Figs 1–4.

Broilers were treated with vehicle (distilled water), 80 mg/kg GTPs, or 160 mg/kg GTPs for 2 or 4 weeks.

https://doi.org/10.1371/journal.pone.0187061.s002

(XLSX)

References

1. Shaw RJ, Lamia KA, Vasquez D, Koo S-H, Bardeesy N, DePinho RA, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005;310(5754):1642–6. pmid:16308421
- View Article
- PubMed/NCBI
- Google Scholar
2. Foretz M, Hébrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010;120(7):2355. pmid:20577053
- View Article
- PubMed/NCBI
- Google Scholar
3. Pollak M. Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment. Nat med. 2014;20(6):591–3. pmid:24901568
- View Article
- PubMed/NCBI
- Google Scholar
4. Yang CS, Hong J. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr. 2013;33:161–81. pmid:23642203
- View Article
- PubMed/NCBI
- Google Scholar
5. Huang J, Wang Y, Xie Z, Zhou Y, Zhang Y, Wan X. The anti-obesity effects of green tea in human intervention and basic molecular studies. Eur J Clin. Nutr. 2014;68(10):1075–87. pmid:25074392
- View Article
- PubMed/NCBI
- Google Scholar
6. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis. 1998;19(10):1771–6. pmid:9806157
- View Article
- PubMed/NCBI
- Google Scholar
7. Huang J, Zhang Y, Zhou Y, Zhang Z, Xie Z, Zhang J, et al. Green Tea Polyphenols Alleviate Obesity in Broiler Chickens through the Regulation of Lipid-Metabolism-Related Genes and Transcription Factor Expression. J Agric Food Chem. 2013;61(36):8565–72. pmid:23992224.
- View Article
- PubMed/NCBI
- Google Scholar
8. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. Journal of Clinical Investigation. 2006;116(7):1776–83. pmid:16823475
- View Article
- PubMed/NCBI
- Google Scholar
9. Banerjee S, Ghoshal S, Porter TD. Phosphorylation of hepatic AMP-activated protein kinase and liver kinase B1 is increased after a single oral dose of green tea extract to mice. Nutr Res. 2012;32(12):985–90. pmid:23244544.
- View Article
- PubMed/NCBI
- Google Scholar
10. Huang HC, Lin JK. Pu-erh tea, green tea, and black tea suppresses hyperlipidemia, hyperleptinemia and fatty acid synthase through activating AMPK in rats fed a high-fructose diet. Food funct. 2012;3(2):170–7. pmid:22127373
- View Article
- PubMed/NCBI
- Google Scholar
11. Murase T, Misawa K, Haramizu S, Hase T. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol. 2009;78(1):78–84. pmid:19447226.
- View Article
- PubMed/NCBI
- Google Scholar
12. Sae-Tan S, Grove KA, Lambert JD. Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res. 2011;64(2):146–54. pmid:21193040
- View Article
- PubMed/NCBI
- Google Scholar
13. Kandhro A, Sherazi STH, Mahesar SA, Bhanger MI, Younis Talpur M, Rauf A. GC-MS quantification of fatty acid profile including trans FA in the locally manufactured margarines of Pakistan. Food Chem. 2008;109(1):207–11. pmid:26054282
- View Article
- PubMed/NCBI
- Google Scholar
14. Bergen WG, Mersmann HJ. Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models. J nutr. 2005;135(11):2499–502. pmid:16251600
- View Article
- PubMed/NCBI
- Google Scholar
15. Gondret F, Ferré P, Dugail I. ADD-1/SREBP-1 is a major determinant of tissue differential lipogenic capacity in mammalian and avian species. J Lipid Res. 2001;42(1):106–13. pmid:11160371
- View Article
- PubMed/NCBI
- Google Scholar
16. Miyazaki M, Flowers MT, Sampath H, Chu K, Otzelberger C, Liu X, et al. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab. 2007;6(6):484–96. pmid:18054317
- View Article
- PubMed/NCBI
- Google Scholar
17. Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, et al. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med. 2008;21(4):507–11. pmid:18360697
- View Article
- PubMed/NCBI
- Google Scholar
18. Améen C, Lindén D, Larsson B-M, Mode A, Holmäng A, Oscarsson J. Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver. Am J Physiol Endocrinol Metab. 2004;287(6):E1039–E48. pmid:15280151
- View Article
- PubMed/NCBI
- Google Scholar
19. Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, Yamashita N, et al. Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res. 2008;38(11):1122–9. pmid:18684130
- View Article
- PubMed/NCBI
- Google Scholar
20. Zhang C, Chen X, Zhu R-M, Zhang Y, Yu T, Wang H, et al. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice. Toxicol Lett. 2012;212(3):229–40. pmid:22698815
- View Article
- PubMed/NCBI
- Google Scholar
21. Nogalska A, Sucajtys-Szulc E, Swierczynski J. Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. Metabolism. 2005;54(8):1041–7. pmid:16092054
- View Article
- PubMed/NCBI
- Google Scholar
22. Yan K, Deng X, Zhai X, Zhou M, Jia X, Luo L. p38 MAPK and LXRα mediate leptin effect on SREBP-1c expression in hepatic stellate cells. Mol Med. 2012;18:10–8. pmid:21979752
- View Article
- PubMed/NCBI
- Google Scholar
23. Zhai X, Yan K, Fan J, Niu M, Zhou Q, Zhou Y, et al. The β‐catenin pathway contributes to the effects of leptin on SREBP‐1c expression in rat hepatic stellate cells and liver fibrosis. Br J Pharmacol. 2013;169(1):197–212. pmid:23347184
- View Article
- PubMed/NCBI
- Google Scholar
24. Braissant O, Wahli W. Differential expression of peroxisome proliferator-activated receptor-α,-β, and-γ during rat embryonic development. Endocrinology. 1998;139(6):2748–54. pmid:9607781
- View Article
- PubMed/NCBI
- Google Scholar
25. Diot C, Douaire M. Characterization of a cDNA sequence encoding the peroxisome proliferator activated receptor alpha in the chicken. Poult Sci. 1999;78(8):1198–202. pmid:10472847
- View Article
- PubMed/NCBI
- Google Scholar
26. Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J hepatol. 2015;62(3):720–33. pmid:25450203.
- View Article
- PubMed/NCBI
- Google Scholar
27. Barger PM, Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovas Med. 2000;10(6):238–45.
- View Article
- Google Scholar
28. Sa C, Oliveira AR, Machado C, Azevedo M, Pereira-Wilson C. Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside. Evid Based Complement Alternat Med. 2015;2015:647832. pmid:26113868
- View Article
- PubMed/NCBI
- Google Scholar
29. Ni Q, Shao Y, Wang YZ, Jing YH, Zhang YC. Impact of high altitude on the hepatic fatty acid oxidation and synthesis in rats. Biochem Biophys Res Commun. 2014;446(2):574–9. pmid:24613835
- View Article
- PubMed/NCBI
- Google Scholar
30. Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes. 2005;29(6):615–23. pmid:15738931
- View Article
- PubMed/NCBI
- Google Scholar
31. Shrestha S, Ehlers SJ, Lee JY, Fernandez ML, Koo SI. Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J Nutr. 2009;139(4):640–5. pmid:19193814
- View Article
- PubMed/NCBI
- Google Scholar
32. Chen N, Bezzina R, Hinch E, Lewandowski PA, Cameron-Smith D, Mathai ML, et al. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr Res. 2009;29(11):784–93. pmid:19932867
- View Article
- PubMed/NCBI
- Google Scholar
33. Lee MS, Kim CT, Kim Y. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann Nutr Metab. 2009;54(2):151–7. pmid:19390166
- View Article
- PubMed/NCBI
- Google Scholar
34. Hardie DG. AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. Biochem Soc Trans. 2011;39:1–13. pmid:21265739
- View Article
- PubMed/NCBI
- Google Scholar
35. Kim S, Lee M-J, Hong J, Li C, Smith TJ, Yang G-Y, et al. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer. 2000;37(1):41–8. pmid:10965518
- View Article
- PubMed/NCBI
- Google Scholar

[ref1] 1. Shaw RJ, Lamia KA, Vasquez D, Koo S-H, Bardeesy N, DePinho RA, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science. 2005;310(5754):1642–6. pmid:16308421
View Article
PubMed/NCBI
Google Scholar

[2] View Article

[3] PubMed/NCBI

[4] Google Scholar

[ref2] 2. Foretz M, Hébrard S, Leclerc J, Zarrinpashneh E, Soty M, Mithieux G, et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest. 2010;120(7):2355. pmid:20577053
View Article
PubMed/NCBI
Google Scholar

[6] View Article

[7] PubMed/NCBI

[8] Google Scholar

[ref3] 3. Pollak M. Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment. Nat med. 2014;20(6):591–3. pmid:24901568
View Article
PubMed/NCBI
Google Scholar

[10] View Article

[11] PubMed/NCBI

[12] Google Scholar

[ref4] 4. Yang CS, Hong J. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Annu Rev Nutr. 2013;33:161–81. pmid:23642203
View Article
PubMed/NCBI
Google Scholar

[14] View Article

[15] PubMed/NCBI

[16] Google Scholar

[ref5] 5. Huang J, Wang Y, Xie Z, Zhou Y, Zhang Y, Wan X. The anti-obesity effects of green tea in human intervention and basic molecular studies. Eur J Clin. Nutr. 2014;68(10):1075–87. pmid:25074392
View Article
PubMed/NCBI
Google Scholar

[18] View Article

[19] PubMed/NCBI

[20] Google Scholar

[ref6] 6. Suganuma M, Okabe S, Oniyama M, Tada Y, Ito H, Fujiki H. Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis. 1998;19(10):1771–6. pmid:9806157
View Article
PubMed/NCBI
Google Scholar

[22] View Article

[23] PubMed/NCBI

[24] Google Scholar

[ref7] 7. Huang J, Zhang Y, Zhou Y, Zhang Z, Xie Z, Zhang J, et al. Green Tea Polyphenols Alleviate Obesity in Broiler Chickens through the Regulation of Lipid-Metabolism-Related Genes and Transcription Factor Expression. J Agric Food Chem. 2013;61(36):8565–72. pmid:23992224.
View Article
PubMed/NCBI
Google Scholar

[26] View Article

[27] PubMed/NCBI

[28] Google Scholar

[ref8] 8. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. Journal of Clinical Investigation. 2006;116(7):1776–83. pmid:16823475
View Article
PubMed/NCBI
Google Scholar

[30] View Article

[31] PubMed/NCBI

[32] Google Scholar

[ref9] 9. Banerjee S, Ghoshal S, Porter TD. Phosphorylation of hepatic AMP-activated protein kinase and liver kinase B1 is increased after a single oral dose of green tea extract to mice. Nutr Res. 2012;32(12):985–90. pmid:23244544.
View Article
PubMed/NCBI
Google Scholar

[34] View Article

[35] PubMed/NCBI

[36] Google Scholar

[ref10] 10. Huang HC, Lin JK. Pu-erh tea, green tea, and black tea suppresses hyperlipidemia, hyperleptinemia and fatty acid synthase through activating AMPK in rats fed a high-fructose diet. Food funct. 2012;3(2):170–7. pmid:22127373
View Article
PubMed/NCBI
Google Scholar

[38] View Article

[39] PubMed/NCBI

[40] Google Scholar

[ref11] 11. Murase T, Misawa K, Haramizu S, Hase T. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochem Pharmacol. 2009;78(1):78–84. pmid:19447226.
View Article
PubMed/NCBI
Google Scholar

[42] View Article

[43] PubMed/NCBI

[44] Google Scholar

[ref12] 12. Sae-Tan S, Grove KA, Lambert JD. Weight control and prevention of metabolic syndrome by green tea. Pharmacol Res. 2011;64(2):146–54. pmid:21193040
View Article
PubMed/NCBI
Google Scholar

[46] View Article

[47] PubMed/NCBI

[48] Google Scholar

[ref13] 13. Kandhro A, Sherazi STH, Mahesar SA, Bhanger MI, Younis Talpur M, Rauf A. GC-MS quantification of fatty acid profile including trans FA in the locally manufactured margarines of Pakistan. Food Chem. 2008;109(1):207–11. pmid:26054282
View Article
PubMed/NCBI
Google Scholar

[50] View Article

[51] PubMed/NCBI

[52] Google Scholar

[ref14] 14. Bergen WG, Mersmann HJ. Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models. J nutr. 2005;135(11):2499–502. pmid:16251600
View Article
PubMed/NCBI
Google Scholar

[54] View Article

[55] PubMed/NCBI

[56] Google Scholar

[ref15] 15. Gondret F, Ferré P, Dugail I. ADD-1/SREBP-1 is a major determinant of tissue differential lipogenic capacity in mammalian and avian species. J Lipid Res. 2001;42(1):106–13. pmid:11160371
View Article
PubMed/NCBI
Google Scholar

[58] View Article

[59] PubMed/NCBI

[60] Google Scholar

[ref16] 16. Miyazaki M, Flowers MT, Sampath H, Chu K, Otzelberger C, Liu X, et al. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab. 2007;6(6):484–96. pmid:18054317
View Article
PubMed/NCBI
Google Scholar

[62] View Article

[63] PubMed/NCBI

[64] Google Scholar

[ref17] 17. Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, et al. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med. 2008;21(4):507–11. pmid:18360697
View Article
PubMed/NCBI
Google Scholar

[66] View Article

[67] PubMed/NCBI

[68] Google Scholar

[ref18] 18. Améen C, Lindén D, Larsson B-M, Mode A, Holmäng A, Oscarsson J. Effects of gender and GH secretory pattern on sterol regulatory element-binding protein-1c and its target genes in rat liver. Am J Physiol Endocrinol Metab. 2004;287(6):E1039–E48. pmid:15280151
View Article
PubMed/NCBI
Google Scholar

[70] View Article

[71] PubMed/NCBI

[72] Google Scholar

[ref19] 19. Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, Yamashita N, et al. Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res. 2008;38(11):1122–9. pmid:18684130
View Article
PubMed/NCBI
Google Scholar

[74] View Article

[75] PubMed/NCBI

[76] Google Scholar

[ref20] 20. Zhang C, Chen X, Zhu R-M, Zhang Y, Yu T, Wang H, et al. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice. Toxicol Lett. 2012;212(3):229–40. pmid:22698815
View Article
PubMed/NCBI
Google Scholar

[78] View Article

[79] PubMed/NCBI

[80] Google Scholar

[ref21] 21. Nogalska A, Sucajtys-Szulc E, Swierczynski J. Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. Metabolism. 2005;54(8):1041–7. pmid:16092054
View Article
PubMed/NCBI
Google Scholar

[82] View Article

[83] PubMed/NCBI

[84] Google Scholar

[ref22] 22. Yan K, Deng X, Zhai X, Zhou M, Jia X, Luo L. p38 MAPK and LXRα mediate leptin effect on SREBP-1c expression in hepatic stellate cells. Mol Med. 2012;18:10–8. pmid:21979752
View Article
PubMed/NCBI
Google Scholar

[86] View Article

[87] PubMed/NCBI

[88] Google Scholar

[ref23] 23. Zhai X, Yan K, Fan J, Niu M, Zhou Q, Zhou Y, et al. The β‐catenin pathway contributes to the effects of leptin on SREBP‐1c expression in rat hepatic stellate cells and liver fibrosis. Br J Pharmacol. 2013;169(1):197–212. pmid:23347184
View Article
PubMed/NCBI
Google Scholar

[90] View Article

[91] PubMed/NCBI

[92] Google Scholar

[ref24] 24. Braissant O, Wahli W. Differential expression of peroxisome proliferator-activated receptor-α,-β, and-γ during rat embryonic development. Endocrinology. 1998;139(6):2748–54. pmid:9607781
View Article
PubMed/NCBI
Google Scholar

[94] View Article

[95] PubMed/NCBI

[96] Google Scholar

[ref25] 25. Diot C, Douaire M. Characterization of a cDNA sequence encoding the peroxisome proliferator activated receptor alpha in the chicken. Poult Sci. 1999;78(8):1198–202. pmid:10472847
View Article
PubMed/NCBI
Google Scholar

[98] View Article

[99] PubMed/NCBI

[100] Google Scholar

[ref26] 26. Pawlak M, Lefebvre P, Staels B. Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. J hepatol. 2015;62(3):720–33. pmid:25450203.
View Article
PubMed/NCBI
Google Scholar

[102] View Article

[103] PubMed/NCBI

[104] Google Scholar

[ref27] 27. Barger PM, Kelly DP. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovas Med. 2000;10(6):238–45.
View Article
Google Scholar

[106] View Article

[107] Google Scholar

[ref28] 28. Sa C, Oliveira AR, Machado C, Azevedo M, Pereira-Wilson C. Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside. Evid Based Complement Alternat Med. 2015;2015:647832. pmid:26113868
View Article
PubMed/NCBI
Google Scholar

[109] View Article

[110] PubMed/NCBI

[111] Google Scholar

[ref29] 29. Ni Q, Shao Y, Wang YZ, Jing YH, Zhang YC. Impact of high altitude on the hepatic fatty acid oxidation and synthesis in rats. Biochem Biophys Res Commun. 2014;446(2):574–9. pmid:24613835
View Article
PubMed/NCBI
Google Scholar

[113] View Article

[114] PubMed/NCBI

[115] Google Scholar

[ref30] 30. Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes. 2005;29(6):615–23. pmid:15738931
View Article
PubMed/NCBI
Google Scholar

[117] View Article

[118] PubMed/NCBI

[119] Google Scholar

[ref31] 31. Shrestha S, Ehlers SJ, Lee JY, Fernandez ML, Koo SI. Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J Nutr. 2009;139(4):640–5. pmid:19193814
View Article
PubMed/NCBI
Google Scholar

[121] View Article

[122] PubMed/NCBI

[123] Google Scholar

[ref32] 32. Chen N, Bezzina R, Hinch E, Lewandowski PA, Cameron-Smith D, Mathai ML, et al. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Nutr Res. 2009;29(11):784–93. pmid:19932867
View Article
PubMed/NCBI
Google Scholar

[125] View Article

[126] PubMed/NCBI

[127] Google Scholar

[ref33] 33. Lee MS, Kim CT, Kim Y. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann Nutr Metab. 2009;54(2):151–7. pmid:19390166
View Article
PubMed/NCBI
Google Scholar

[129] View Article

[130] PubMed/NCBI

[131] Google Scholar

[ref34] 34. Hardie DG. AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. Biochem Soc Trans. 2011;39:1–13. pmid:21265739
View Article
PubMed/NCBI
Google Scholar

[133] View Article

[134] PubMed/NCBI

[135] Google Scholar

[ref35] 35. Kim S, Lee M-J, Hong J, Li C, Smith TJ, Yang G-Y, et al. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer. 2000;37(1):41–8. pmid:10965518
View Article
PubMed/NCBI
Google Scholar

[137] View Article

[138] PubMed/NCBI

[139] Google Scholar

Figures

Abstract

Introduction

Materials and methods

Reagents

Animal feeding and sampling

Evaluation of hepatic lipid content and fatty acid profile

Real-time PCR analysis

SDS-PAGE and Western blotting

Activity of lipid metabolic enzymes

Measurement of the concentration of hepatic malonyl-CoA

Statistical analysis

Results

GTP supplementation on the liver-to-body ratio and abdominal fat mass

GTP supplementation on the hepatic lipid content and oleic acid proportion

GTPs altered the expression of lipid-metabolizing genes in the liver

GTPs alter the activity of lipid metabolic enzymes in the liver

GTPs influence on malonyl-CoA concentration in the liver

GTPs affect the phosphorylation levels of hepatic AMPK and ACACA

Discussion

Concluding remarks

Supporting information

S1 Fig. Effects of GTPs on mRNA levels of AMPK genes in the liver.

S1 Table. Raw data for Figs 1–4.

References